Filing Details

Accession Number:
0000899243-18-004457
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-16 19:54:26
Reporting Period:
2018-02-15
Accepted Time:
2018-02-16 19:54:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1466301 Clovis Oncology Inc. CLVS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1268304 C Gillian Ivers-Read C/O Clovis Oncology, Inc.
5500 Flatiron Parkway, Suite 100
Boulder CO 80301
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-02-15 3,000 $54.09 180,571 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 6, 2017.